Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-20

Clinical Trial Update: Sodium Thiosulfate Otoprotection During Salvage Cisplatin Therapy [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating sodium thiosulfate to protect against cisplatin-induced ototoxicity during salvage cisplatin therapy is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CISPLATIN (cisplatin)
  • Sodium thiosulfate (sodium thiosulfate)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Ototoxicity, Drug-Induced | EARLY_Phase 1 | Status: SUSPENDED